| 2025-11-04 |
详情>>
股本变动：
变动后总股本568570.76万股
|
| 2025-11-04 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.66美元,归母净利润94.19亿美元,同比去年增长23.59%
|
| 2025-11-04 |
财报披露：
美东时间 2025-11-04 盘前发布财报
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益1.03美元,归母净利润58.77亿美元,同比去年增长86.22%
|
| 2025-05-05 |
详情>>
业绩披露：
2025年一季报每股收益0.52美元,归母净利润29.67亿美元,同比去年增长-4.75%
|
| 2025-03-13 |
股东大会：
将于2025-04-24召开股东大会
会议内容 ▼▲
- 1.To elect 13 members of the Board of Directors, each until our next Annual Meeting and until his or her successor has been duly elected and qualified.
2.To ratify the selection of KPMG LLP as our independent registered public accounting firm for 2025.
3.To conduct an advisory vote to approve our executive compensation.
4.To consider two shareholder proposals, if properly presented at the Annual Meeting.
5.To transact any other business that properly comes before the Annual Meeting or any adjournment or postponement of the Meeting.
|
| 2025-02-27 |
详情>>
内部人交易：
McDermott Michael等共交易23笔
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益5.59美元,归母净利润313.72亿美元,同比去年增长42.74%
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益1.42美元,归母净利润80.31亿美元,同比去年增长279.00%
|
| 2024-11-04 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.35美元,归母净利润76.21亿美元,同比去年增长38.87%
|
| 2024-08-05 |
详情>>
业绩披露：
2024年中报每股收益0.56美元,归母净利润31.56亿美元,同比去年增长-59.9%
|
| 2024-08-05 |
详情>>
业绩披露：
2023年中报每股收益1.40美元,归母净利润78.70亿美元,同比去年增长-55.71%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年一季报每股收益0.55美元,归母净利润31.15亿美元,同比去年增长-43.8%
|
| 2024-03-14 |
股东大会：
将于2024-04-25召开股东大会
会议内容 ▼▲
- 1.To elect 12 members of the Board of Directors, each until our next Annual Meeting and until his or her successor has been duly elected and qualified.
2.To ratify the selection of KPMG LLP as our independent registered public accounting firm for 2024.
3.To approve the Amended and Restated Pfizer Inc. 2019 Stock Plan.
4.To conduct an advisory vote to approve our executive compensation.
5.To consider 4 shareholder proposals, if properly presented at the Annual Meeting.
6.To transact any other business that properly comes before the Annual Meeting or any adjournment or postponement of the Meeting.
|
| 2024-02-22 |
详情>>
业绩披露：
2023年年报每股收益0.38美元,归母净利润21.19亿美元,同比去年增长-93.25%
|
| 2023-11-08 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.97美元,归母净利润54.88亿美元,同比去年增长-79.19%
|
| 2023-03-16 |
股东大会：
将于2023-04-27召开股东大会
会议内容 ▼▲
- 1.To elect 12 members of the Board of Directors, each until our next Annual Meeting and until his or her successor has been duly elected and qualified.
2.To ratify the selection of KPMG LLP as our independent registered public accounting firm for 2023.
3.To conduct an advisory vote to approve our executive compensation.
4.To conduct an advisory vote on the frequency of future advisory votes on executive compensation.
5.To consider five shareholder proposals, if properly presented at the Annual Meeting.
6.To transact any other business that properly comes before the Annual Meeting or any adjournment or postponement of the Meeting.
|
| 2023-03-16 |
股东大会：
将于2023-04-27召开股东大会
会议内容 ▼▲
- 1.To elect 12 members of the Board of Directors, each until our next Annual Meeting and until his or her successor has been duly elected and qualified.
2.To ratify the selection of KPMG LLP as our independent registered public accounting firm for 2023.
3.To conduct an advisory vote to approve our executive compensation.
4.To conduct an advisory vote on the frequency of future advisory votes on executive compensation.
5.To consider five shareholder proposals, if properly presented at the Annual Meeting.
6.To transact any other business that properly comes before the Annual Meeting or any adjournment or postponement of the Meeting.
|
| 2022-03-17 |
股东大会：
将于2022-04-28召开股东大会
会议内容 ▼▲
- 1.To elect 12 members of the Board of Directors, each until our next Annual Meeting and until his or her successor has been duly elected and qualified.
2.To ratify the selection of KPMG LLP as our independent registered public accounting firm for 2022.
3.To conduct an advisory vote to approve our executive compensation.
4.To consider 5 shareholder proposals, if properly presented at the Annual Meeting.
5.To transact any other business that properly comes before the Annual Meeting and any adjournment or postponement of the Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-12 |
股东大会：
将于2021-04-22召开股东大会
会议内容 ▼▲
- 1.To elect 12 members of the Board of Directors, each until our next Annual Meeting and until his or her successor has been duly elected and qualified.
2.To ratify the selection of KPMG LLP as our independent registered public accounting firm for the 2021 fiscal year.
3.To conduct an advisory vote to approve our executive compensation.
4.To consider 3 shareholder proposals, if properly presented at the Meeting.
5.To transact any other business that properly comes before the Meeting and any adjournment or postponement of the Meeting.
|
| 2020-04-23 |
除权日：
美东时间 2020-05-07 每股派息0.38美元
|
| 2020-03-13 |
股东大会：
将于2020-04-23召开股东大会
会议内容 ▼▲
- 1.To elect 13 members of the Board of Directors, each until our next Annual Meeting and until his or her successor has been duly elected and qualified.
2.To ratify the selection of KPMG LLP as our independent registered public accounting firm for the 2020 fiscal year.
3.To conduct an advisory vote to approve our executive compensation.
4.To consider 5 shareholder proposals, if properly presented at the Meeting.
5.To transact any other business that properly comes before the Meeting and any adjournment or postponement of the Meeting.
|
| 2019-12-16 |
除权日：
美东时间 2020-01-30 每股派息0.38美元
|
| 2019-09-24 |
除权日：
美东时间 2019-11-07 每股派息0.36美元
|
| 2019-06-27 |
除权日：
美东时间 2019-08-01 每股派息0.36美元
|
| 2019-04-25 |
除权日：
美东时间 2019-05-09 每股派息0.36美元
|
| 2019-03-14 |
股东大会：
将于2019-04-25召开股东大会
会议内容 ▼▲
- 1.To elect 11 members of the Board of Directors, each until our next Annual Meeting and/or until his or her successor has been duly elected and qualified.
2.To ratify the selection of KPMG LLP as our independent registered public accounting firm for the 2019 fiscal year.
3.To conduct an advisory vote to approve our executive compensation.
4.To approve the Pfizer Inc. 2019 Stock Plan.
5.To consider 4 shareholder proposals, if properly presented at the Meeting.
6.To transact any other business that properly comes before the Meeting and any adjournment or postponement of the Meeting.
|
| 2018-12-14 |
除权日：
美东时间 2019-01-31 每股派息0.36美元
|
| 2018-09-27 |
除权日：
美东时间 2018-11-08 每股派息0.34美元
|
| 2018-06-28 |
除权日：
美东时间 2018-08-02 每股派息0.34美元
|
| 2018-04-26 |
除权日：
美东时间 2018-05-10 每股派息0.34美元
|
| 2018-03-15 |
股东大会：
将于2018-04-26召开股东大会
会议内容 ▼▲
- 1.To elect 12 members of the Board of Directors, each until our next Annual Meeting and/or until his or her successor has been duly elected and qualified.
2.To ratify the selection of KPMG LLP as our independent registered public accounting firm for the 2018 fiscal year.
3.To conduct an advisory vote to approve our executive compensation.
4.To approve the Pfizer Inc. French Sub-Plan under the 2014 Stock Plan.
5.To consider three shareholder proposals, if properly presented at the Meeting.
6.To transact any other business that properly comes before the Meeting and any adjournment or postponement of the Meeting.
|
| 2017-12-18 |
除权日：
美东时间 2018-02-01 每股派息0.34美元
|
| 2017-09-28 |
除权日：
美东时间 2017-11-09 每股派息0.32美元
|
| 2017-06-22 |
除权日：
美东时间 2017-08-02 每股派息0.32美元
|
| 2017-04-28 |
除权日：
美东时间 2017-05-10 每股派息0.32美元
|
| 2017-03-16 |
股东大会：
将于2017-04-27召开股东大会
会议内容 ▼▲
- 1.To elect 12 members of the Board of Directors, each until our next Annual Meeting and until his or her successor has been duly elected and qualified.
2.To ratify the selection of KPMG LLP as our independent registered public accounting firm for the 2017 fiscal year.
3.To conduct an advisory vote to approve our executive compensation.
4.To conduct an advisory vote on the frequency of future advisory votes on executive compensation.
5.To consider three shareholder proposals, if presented at the Meeting.
6.To transact any other business that properly comes before the Meeting and any adjournment or postponement of the Meeting.
|
| 2016-12-12 |
除权日：
美东时间 2017-02-01 每股派息0.32美元
|
| 2016-09-22 |
除权日：
美东时间 2016-11-08 每股派息0.30美元
|
| 2016-06-23 |
除权日：
美东时间 2016-08-03 每股派息0.30美元
|
| 2016-04-28 |
除权日：
美东时间 2016-05-11 每股派息0.30美元
|
| 2016-03-15 |
股东大会：
将于2016-04-28召开股东大会
会议内容 ▼▲
- 1.To elect 11 members of the Board of Directors named in the Proxy Statement, each until our next Annual Meeting and until his or her successor has been duly elected and qualified.
2.To consider and ratify the selection of KPMG LLP as our independent registered public accounting firm for the 2016 fiscal year.
3.To conduct an advisory vote to approve our executive compensation.
4.To consider four shareholder proposals, if presented at the Meeting.
5.To transact any other business that properly comes before the Meeting and any adjournment or postponement of the Meeting.
|
| 2015-12-14 |
除权日：
美东时间 2016-02-03 每股派息0.30美元
|
| 2015-10-29 |
复牌提示：
2015-10-29 09:29:44 停牌，复牌日期 2015-10-29 10:15:48
|
| 2015-09-25 |
除权日：
美东时间 2015-11-04 每股派息0.28美元
|
| 2015-06-25 |
除权日：
美东时间 2015-08-05 每股派息0.28美元
|
| 2015-04-23 |
除权日：
美东时间 2015-05-06 每股派息0.28美元
|
| 2014-12-15 |
除权日：
美东时间 2015-02-04 每股派息0.28美元
|
| 2014-11-06 |
除权日：
美东时间 2014-11-05 每股派息0.26美元
|
| 2014-06-26 |
除权日：
美东时间 2014-07-30 每股派息0.26美元
|
| 2014-04-24 |
除权日：
美东时间 2014-05-07 每股派息0.26美元
|
| 2013-12-16 |
除权日：
美东时间 2014-02-05 每股派息0.26美元
|
| 2013-10-24 |
除权日：
美东时间 2013-11-06 每股派息0.24美元
|
| 2013-06-27 |
除权日：
美东时间 2013-07-31 每股派息0.24美元
|
| 2013-04-25 |
除权日：
美东时间 2013-05-08 每股派息0.24美元
|
| 2012-12-17 |
除权日：
美东时间 2013-01-30 每股派息0.24美元
|
| 2012-10-25 |
除权日：
美东时间 2012-11-07 每股派息0.22美元
|
| 2012-06-28 |
除权日：
美东时间 2012-08-01 每股派息0.22美元
|
| 2012-04-26 |
除权日：
美东时间 2012-05-09 每股派息0.22美元
|
| 2011-12-12 |
除权日：
美东时间 2012-02-01 每股派息0.22美元
|
| 2011-10-27 |
除权日：
美东时间 2011-11-08 每股派息0.20美元
|
| 2011-06-23 |
除权日：
美东时间 2011-08-03 每股派息0.20美元
|
| 2011-04-28 |
除权日：
美东时间 2011-05-11 每股派息0.20美元
|
| 2010-12-13 |
除权日：
美东时间 2011-02-02 每股派息0.20美元
|
| 2010-10-28 |
除权日：
美东时间 2010-11-04 每股派息0.18美元
|
| 2010-06-23 |
除权日：
美东时间 2010-08-04 每股派息0.18美元
|